1. Medtech Insight
  2. >>Geography
  3. >>Europe

Old Tech, New Tricks: The ‘Game-Changing’ Potential In Thermal Imaging For Diabetes

 
• By Eliza Slawther

Thermal imaging technology has existed for almost 100 years, but still has plenty of untapped power in medical diagnostics. Finnish healthtech Thermidas explains why its AI-assisted thermal imaging software is a potential game-changer for people with diabetes.

Thermal Imaging
• Source: Shutterstock

Diabetic foot ulcers are estimated to cost the UK’s health system £1 billion per year, while costs seven times as high have been cited in the US. Could the answer to early detection – and in many cases prevention – of diabetic foot ulcers lie in something as simple and non-invasive as thermal imaging technology? Finland’s Thermidas Oy believes so.

Diabetic foot ulcers (DFUs) can, in serious but not uncommon cases, lead to amputations, with more than 169 amputations per week in the UK. But tracking temperature changes in the...

“Multiple studies have shown that a contralateral skin temperature difference of 2.2°C can be a predictor of an ulcer developing,” Taylor explained, “hence why daily temperature measuring of high-risk feet...

More from Europe

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

MORE Details On MHRA’s Online Platform For Post Market Surveillance

 
• By Ashley Yeo

Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.

More from Geography

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.

MORE Details On MHRA’s Online Platform For Post Market Surveillance

 
• By Ashley Yeo

Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.